{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T13:14:45Z","timestamp":1746710085050,"version":"3.40.5"},"reference-count":31,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,5,1]]},"abstract":"<jats:p>Objective. To examine the association of maternal hard drug use (injection drugs, cocaine, and opiates) on lymphocyte subsets and clinical morbidity in uninfected infants who are born to human immunodeficiency virus-infected mothers who were enrolled in the Women and Infants Transmission Study (1990\u20132000).<\/jats:p><jats:p>Methods. Maternal hard drug use was identified by self-report and\/or urine toxicology. Infant evaluations occurred at birth and at 1, 2, 4, 6, 9, 12, 18, and 24 months of age.<\/jats:p><jats:p>Results. A total of 401 (28%) of the 1436 uninfected infants were born to drug-using mothers. Maternal CD4 lymphocyte percentage and RNA at delivery were not significantly different between drug users and nonusers. Infants who were born to drug-using mothers had lower mean gestational age (37.8 vs 38.5 weeks) and birth weight (2.9 vs 3.1 kg). Infants with intrauterine drug exposure had lower CD4 lymphocyte percentage over the first 4 months of life after adjusting for covariates and higher natural killer lymphocyte percentage. When the analysis was stratified by time period of entry, the incidence of clinical events was not different between infants who were born to drug users versus nonusers.<\/jats:p><jats:p>Conclusion. Maternal hard drug use is associated with immunologic changes in infants early in life, although these changes did not seem to be associated with increased risk of infections.<\/jats:p>","DOI":"10.1542\/peds.113.5.1260","type":"journal-article","created":{"date-parts":[[2004,8,14]],"date-time":"2004-08-14T00:53:04Z","timestamp":1092444784000},"page":"1260-1266","source":"Crossref","is-referenced-by-count":8,"title":["Immune Parameters and Morbidity in Hard Drug and Human Immunodeficiency Virus-xposed but Uninfected Infants"],"prefix":"10.1542","volume":"113","author":[{"given":"Natalie","family":"Neu","sequence":"first","affiliation":[{"name":"Columbia University, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Leighty","sequence":"additional","affiliation":[{"name":"C-TASC, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Adeniyi-Jones","sequence":"additional","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemente","family":"Diaz","sequence":"additional","affiliation":[{"name":"University of Puerto Rico, San Juan, Puerto Rico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Handelsman","sequence":"additional","affiliation":[{"name":"State University of New York Downstate, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Kaufman","sequence":"additional","affiliation":[{"name":"Boston Medical Center, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary E.","family":"Paul","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Rich","sequence":"additional","affiliation":[{"name":"University of Illinois, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynne","family":"Mofenson","sequence":"additional","affiliation":[{"name":"National Institute of Child Health and Human Development, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Pitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Women and Infants Transmission Study","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2004,5,1]]},"reference":[{"unstructured":"Eisenstein TK, Hillburger ME, Lawrence DMP. Immunomodulation by morphine and other opioids. In: Friedman H, Klein TW, Specter S, eds. Drugs of Abuse, Immunity and Infections. Boca Raton, FL: CRC Press; 1996:103\u2013120","key":"2021121010065713900_R1"},{"doi-asserted-by":"crossref","unstructured":"Yeager MP, Colacchio TA, Yu CT, et al. Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers. Anesthesiology.\u20081995;83:500\u2013508","key":"2021121010065713900_R2","DOI":"10.1097\/00000542-199509000-00008"},{"doi-asserted-by":"crossref","unstructured":"Culver K, Ammann A, Partridge J, Wong D, Wara D, Cowan M. Lymphocyte abnormalities in infants born to drug-abusing mothers. J Pediatr.\u20081987;111:230\u2013235","key":"2021121010065713900_R3","DOI":"10.1016\/S0022-3476(87)80073-2"},{"doi-asserted-by":"crossref","unstructured":"Scheidgger C, Zimmerli W. Infectious complications in drug addicts: seven year review of 269 hospitalized narcotics abusers in Switzerland. Rev Infect Dis.\u20081989;11:486\u2013493","key":"2021121010065713900_R4","DOI":"10.1093\/clinids\/11.3.486"},{"doi-asserted-by":"crossref","unstructured":"Haverkos HW, Lange WR. Serious infections other than human immunodeficiency virus among intravenous drug users. J Infect Dis.\u20081990;161:894\u2013902","key":"2021121010065713900_R5","DOI":"10.1093\/infdis\/161.5.894"},{"doi-asserted-by":"crossref","unstructured":"MacFarlane A, Peng X, Meissler J, et al. Morphine increases susceptibility to oral salmonella typhimurium infection. J Infect Dis.\u20082000;181:1350\u20131358","key":"2021121010065713900_R6","DOI":"10.1086\/315403"},{"doi-asserted-by":"crossref","unstructured":"Carballo-Dieguez A, Sahs J, Goetz R, el Sadr W, Sorell S, Gorman J. The effect of methadone on immunological parameters among HIV-positive and HIV-negative drug users. Am J Drug Alcohol Abuse.\u20081994;20:317\u2013329","key":"2021121010065713900_R7","DOI":"10.3109\/00952999409106017"},{"doi-asserted-by":"crossref","unstructured":"McLachlan C, Crofts N, Wodak A, Crowe S. The effects of methadone on immune function among injecting drug users: a review. Addiction.\u20081993;88:257\u2013263","key":"2021121010065713900_R8","DOI":"10.1111\/j.1360-0443.1993.tb00809.x"},{"doi-asserted-by":"crossref","unstructured":"Carr D, France C. Immune alternations in morphine-treated rhesus monkeys. J Pharmacol Exp Ther.\u20081993;267:9\u201315","key":"2021121010065713900_R9","DOI":"10.1007\/978-1-4615-2980-4_6"},{"doi-asserted-by":"crossref","unstructured":"Van Dyke C, Stesin A, Jones R, Chuntharapai A, Seaman W. Cocaine increases natural killer cell activity. J Clin Invest.\u20081986;77:1387\u20131390","key":"2021121010065713900_R10","DOI":"10.1172\/JCI112445"},{"doi-asserted-by":"crossref","unstructured":"Ruiz, P, Berho M, Steele B, Hao L. Peripheral human lymphocyte maintenance of immune functional capacity and phenotypic characteristics following in vivo cocaine exposure. Clin Immunol Immunopathol.\u20081998;88:271\u2013276","key":"2021121010065713900_R11","DOI":"10.1006\/clin.1998.4579"},{"doi-asserted-by":"crossref","unstructured":"Wybran J, Appelboom T, Famaey JP, Govaerts A. Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes. J Immunol.\u20081979;124:1068\u20131070","key":"2021121010065713900_R12","DOI":"10.4049\/jimmunol.123.3.1068"},{"doi-asserted-by":"crossref","unstructured":"Peterson P, Gekker G, Brummitt C, et al. Suppression of human peripheral blood mononuclear cell function by methadone and morphine. J Infect Dis.\u20081989;159:480\u2013487","key":"2021121010065713900_R13","DOI":"10.1093\/infdis\/159.3.480"},{"doi-asserted-by":"crossref","unstructured":"Thomas P, House R, Bhargava H. Direct cellular immunomodulation produced by diacetylmorphine (heroin) or methadone. Gen Pharmacol.\u20081995;26:123\u2013130","key":"2021121010065713900_R14","DOI":"10.1016\/0306-3623(94)00162-G"},{"doi-asserted-by":"crossref","unstructured":"Roy S, Ramakrishnan S, Loh HH, Lee NM. Chronic morphine treatment selectively suppresses macrophage colony formation in bone marrow. Eur J Pharmacol.\u20081991;195:359\u2013363","key":"2021121010065713900_R15","DOI":"10.1016\/0014-2999(91)90476-7"},{"unstructured":"Bussiere JL, Adler MW, Rogers TJ, Eisenstein TK. Cytokine reversal of morphine-induced suppression of the antibody response. J Pharmacol Exp Ther.\u20081993;264:59","key":"2021121010065713900_R16"},{"unstructured":"Szabo I, Rojavin M, Bussiere J, Eisenstein TK, Adler MW. Suppression of peritoneal macrophage phagocytosis of candida albicans by opioids. J Pharmcol Exp Ther.\u20081993;267:703","key":"2021121010065713900_R17"},{"unstructured":"Choi Y, Chuang L, Lam K, et al. Inhibition of chemokine-induced chemotaxis of monkey leukocytes by mu-opioid receptor agonists. In Vivo.\u20081999;5:389\u2013396","key":"2021121010065713900_R18"},{"doi-asserted-by":"crossref","unstructured":"Grimm M, Ben-Baruch A, Taub D, Howard O, Wang J, Oppenheim J. Opiate inhibition of chemokine-induced chemotaxis. Ann N Y Acad Sci.\u20081998;840:9\u201320","key":"2021121010065713900_R19","DOI":"10.1111\/j.1749-6632.1998.tb09544.x"},{"doi-asserted-by":"crossref","unstructured":"Welters I, Menzebach A, Goumon Y, et al. Morphine inhibits NF-\u03baB nuclear binding in human neutrophils and monocytes by a nitric oxide-dependent mechanism. Anesthesiology.\u20082000;6:1677\u20131684","key":"2021121010065713900_R20","DOI":"10.1097\/00000542-200006000-00027"},{"doi-asserted-by":"crossref","unstructured":"Rodriquez E, Mofenson L, Chang BH, et al. Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission. AIDS.\u20081996;10:273\u2013282","key":"2021121010065713900_R21","DOI":"10.1097\/00002030-199603000-00006"},{"doi-asserted-by":"crossref","unstructured":"Hollinger FB, Bremer JW, Myers LE, Gold JWM, McQuay L, HIH\/NIAID\/DAIDS\/ACTG Virology Laboratories. Standardization of sensitive human immunodeficiency virus co-culture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. J Clin Microbiol.\u20081992;30:1787\u20131794","key":"2021121010065713900_R22","DOI":"10.1128\/jcm.30.7.1787-1794.1992"},{"unstructured":"Mofenson L, Bethel J, Moye J, Flyer P, Nugent R, National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group. Effect of intravenous immunoglobulin (IVIG) on CD4+ lymphocyte decline in HIV-infected children in a clinical trial of IVIG infection prophylaxis. J Acquir Immune Defic Syndr.\u20081993;6:1103\u20131113","key":"2021121010065713900_R23"},{"doi-asserted-by":"crossref","unstructured":"Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika.\u20081986;73:13\u201322","key":"2021121010065713900_R24","DOI":"10.1093\/biomet\/73.1.13"},{"doi-asserted-by":"crossref","unstructured":"Gesner M, Papaevangelou V, Kim M, et al. Alteration in the proportion of CD4 T lymphocytes in a subgroup of human immunodeficiency virus-exposed-uninfected children. Pediatrics.\u20081994;4:624\u2013630","key":"2021121010065713900_R25","DOI":"10.1542\/peds.93.4.624"},{"doi-asserted-by":"crossref","unstructured":"Clerici M, Saresella M, Colombo F, et al. T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood.\u20082000;12:3866\u20133871","key":"2021121010065713900_R26","DOI":"10.1182\/blood.V96.12.3866"},{"doi-asserted-by":"crossref","unstructured":"Nielsen SD, Jeppeson D, Kolte L, et al. Impaired progenitor cell function in HIV-negative infants of HIV-positive mothers results in decreased thymic output and low CD4 counts. Blood.\u20082001;98:398\u2013404","key":"2021121010065713900_R27","DOI":"10.1182\/blood.V98.2.398"},{"doi-asserted-by":"crossref","unstructured":"Rosen T, Johnson H. Children of methadone-maintained mothers: follow-up to 18 months of age. J Pediatr.\u20081982;101:192\u2013196","key":"2021121010065713900_R28","DOI":"10.1016\/S0022-3476(82)80115-7"},{"doi-asserted-by":"crossref","unstructured":"Rich K. Immunologic function and AIDS in drug-exposed infants. In: Chasnoff I, ed. Drug Use in Pregnancy: Mother and Child. Boston, MA: MTP Press Limited; 1986:136","key":"2021121010065713900_R29","DOI":"10.1007\/978-94-009-4157-1_13"},{"unstructured":"Roizman B, Whitley RJ, Lopez C. The Human Herpes Viruses. New York, NY: Raven Press; 1993:89","key":"2021121010065713900_R30"},{"doi-asserted-by":"crossref","unstructured":"Teele D, Klein J, Roser B, the Greater Boston Otitis Media Study Group. Epidemiology of otitis media during the first seven years of life in children in Greater Boston: a prospective, cohort study. J Infect Dis.\u20081989;160:83\u201394","key":"2021121010065713900_R31","DOI":"10.1093\/infdis\/160.1.83"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/113\/5\/1260\/1003660\/zpe00504001260.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/113\/5\/1260\/1003660\/zpe00504001260.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T05:40:47Z","timestamp":1682746847000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/113\/5\/1260\/66704\/Immune-Parameters-and-Morbidity-in-Hard-Drug-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5,1]]},"references-count":31,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2004,5,1]]},"published-print":{"date-parts":[[2004,5,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.113.5.1260","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"type":"print","value":"0031-4005"},{"type":"electronic","value":"1098-4275"}],"subject":[],"published":{"date-parts":[[2004,5,1]]}}}